Amedisys, inc. announces board changes

On october 17, 2019, the board of directors of amedisys, inc. (the company), upon the recommendation of the nominating and corporate governance committee of the board and by unanimous vote of the board, increased the size of the board by three directors to a total of ten directors effective november 1, 2019 (the effective date), and appointed vickie l. capps, molly j. coye, md, and teresa l. kline to fill the resulting vacancies, also effective on the effective date. there are no arrangements between ms. capps, dr. coye or ms. kline and any other person pursuant to which they were selected to become directors. it is intended that ms. capps, dr. coye and ms. kline will be nominees for election to the board at the company’s 2020 annual meeting of stockholders (the 2020 annual meeting). on october 17, 2019, donald a. washburn notified the board that he intends to retire as a director and does not wish to seek re-election at the 2020 annual meeting. accordingly, mr. washburn will not be nominated by the board for election at the 2020 annual meeting, and mr. washburn’s term as a director will end when his current term expires at the 2020 annual meeting. mr. washburn’s decision to retire and not to stand for re-election is not the result of any disagreement with management or the board related to the company’s operations, policies or practices. mr. washburn will continue to serve as a member of the audit, compensation, and nominating and corporate governance committees until the end of his term or until committee assignments are changed. on october 17, 2019, mr. washburn also retired as the chairman of the board effective immediately. the board elected paul b. kusserow, the company’s president and chief executive officer, as the chairman of the board on october 17, 2019, effective immediately. because mr. kusserow is an executive officer of the company, the independent directors of the board appointed richard a. lechleiter, one of the company’s independent directors, as lead director to lead the board in fulfilling its duties effectively, efficiently and independent of management, in accordance with the company’s by-laws and corporate governance guidelines.
AMED Ratings Summary
AMED Quant Ranking